Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies Article (Web of Science)

cited authors

  • Ansell, Stephen M.; Flinn, Ian; Taylor, Matthew H.; Sikic, Branimir, I; Brody, Joshua; Nemunaitis, John; Feldman, Andrew; Hawthorne, Thomas R.; Rawls, Tracey; Keler, Tibor; Yellin, Michael J.

publication date

  • May 12, 2020

webpage

published in

category

start page

  • 1917

end page

  • 1926

volume

  • 4

issue

  • 9